Avesthagen in deal with Elpen for biosimilar Aranesp in parts of Europe

Avesthagen in deal with Elpen for biosimilar Aranesp in parts of Europe

Avesthagen Pharma AG, a unit of India’s Avesthagen Ltd, has signed an agreement with Greek life sciences.. View…

ByByadminNov 21, 2013
Avesthagen Pharma signs pact with Elpen Pharmaceuticals for biosimilar AVDESPTM

Avesthagen Pharma signs pact with Elpen Pharmaceuticals for biosimilar AVDESPTM

Avesthagen Pharma has announced an agreement with Elpen Pharmaceutical Co, a leader in life-sciences for the distribution.. View…

ByByadminNov 20, 2013
Avesthagen Pharma signs pact with Elpen Pharmaceuticals

Avesthagen Pharma signs pact with Elpen Pharmaceuticals

AVDESP is a biosimilar for Darbepoetin alfa Aranesp, which is used for treating anaemia resulting from chronic.. View…

ByByadminNov 2, 2013
Avesthagen signs license agreement with AvestaDHATM

Avesthagen signs license agreement with AvestaDHATM

Avesthagen, an integrated systems biology platform company has announced a license agreement with AvestaDHATM for animal feed application..…

ByByadminSep 20, 2013
Image Not Found
Global Cancer Biosimilar Market 2019 BioXpress Therapeutics, Boehringer Ingelheim, AvesthaGen, Biocon, Amega Biotech

Global Cancer Biosimilar Market 2019 BioXpress Therapeutics, Boehringer Ingelheim, AvesthaGen, Biocon, Amega Biotech

The Cancer Biosimilar Market report starts from an overview of Industry Chain structure,.. View More

ByByadminDec 11, 2019
Cancer Biosimilar Market : Recent Industry Trends and Projected Industry Growth by 2024

Cancer Biosimilar Market : Recent Industry Trends and Projected Industry Growth by 2024

The global Cancer Biosimilar industry report has been assembled using primary and secondary research methods.. View More

ByByadminDec 6, 2019
error: